BlinkLab Limited

Equities

BB1

AU0000322851

Software

Market Closed - Australian S.E. 02:10:04 2024-05-21 am EDT 5-day change 1st Jan Change
0.37 AUD -3.27% Intraday chart for BlinkLab Limited 0.00% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chart BlinkLab Limited
More charts
BlinkLab Limited is an Australia-based company focused on the development and commercialization of smartphone-neurobehavioral testing, to aid in the diagnosis of ASD, ADHD, schizophrenia and other neurodevelopmental conditions. The Company’s tests include eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI) and habituation of eye blink response, which serve as biomarkers for neurological and psychiatric disorders (BlinkLab Tests). The BlinkLab Device (BlinkLab Dx) consists of BlinkLab App, a mobile application for patients, caregivers and/or parents, effectively a front-end tool that helps collect test subjects’ information and responses to the BlinkLab Tests in real time (BlinkLab App), and BlinkLab Portal, which includes a fully built secure database and content management system (CMS) as well as experimenter’s portal that allows for full customization of the neurometric tests as well as data analysis, annotation and visualization tools (the BlinkLab Portal).
More about the company
  1. Stock Market
  2. Equities
  3. BB1 Stock
  4. News BlinkLab Limited
  5. BlinkLab to Start Trading in Australia After AU$7 Million IPO
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW